Patents by Inventor Dieter Schinzer

Dieter Schinzer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6350878
    Abstract: The invention relates to a method of synthesis for a compound of formula (I), wherein R is a heterocyclyl moiety and X1, X2, X3 and X4 are, independently of each other, protecting groups, which is appropriate for the synthesis of epothilone B and desoxyepothione B.
    Type: Grant
    Filed: November 17, 2000
    Date of Patent: February 26, 2002
    Assignee: Novartis AG
    Inventors: Karl-Heinz Altmann, Armin Bauer, Dieter Schinzer
  • Patent number: 6156905
    Abstract: The invention relates to a process for the production of epothilones and intermediate products within the process.Epothilones A and B are natural substances, which can be produced by microorganisms, and the taxols have similar properties and are thus of particular interest in pharmaceutical chemistry.
    Type: Grant
    Filed: January 6, 2000
    Date of Patent: December 5, 2000
    Assignee: Novartis AG
    Inventors: Dieter Schinzer, Anja Limberg, Oliver M. Bohm, Armin Bauer, Martin Cordes
  • Patent number: 6043372
    Abstract: The invention relates to a process for the production of epothilones and intermediate products within the process.Epothilones A and B are natural substances, which can be produced by microorganisms, and the taxols have similar properties and are thus of particular interest in pharmaceutical chemistry.
    Type: Grant
    Filed: June 25, 1999
    Date of Patent: March 28, 2000
    Assignee: Novartis AG
    Inventors: Dieter Schinzer, Anja Limberg, Oliver M. Bohm, Armin Bauer, Martin Cordes
  • Patent number: 5969145
    Abstract: The invention relates to a process for the production of epothilones and intermediate products within the process.Epothilones A and B are natural substances, which can be produced by microorganisms, and the taxols have similar properties and are thus of particular interest in pharmaceutical chemistry.
    Type: Grant
    Filed: September 2, 1997
    Date of Patent: October 19, 1999
    Assignee: Novartis AG
    Inventors: Dieter Schinzer, Anja Limberg, Oliver M. Bohm, Armin Bauer, Martin Cordes